Why is Shukra Pharma. falling/rising?

As of 01-Jul, Shukra Pharmaceuticals Ltd is experiencing a price increase, with its current price at 15.05, reflecting a rise of 0.71 or 4.95%. The stock has shown strong performance recently, gaining 12.31% over the last three days and outperforming its sector by 5.16% today. Over the past year, it has generated a remarkable return of 37.82%, significantly higher than the market's average return of 3.20%. Despite a decline in delivery volume by 28.2% against the 5-day average, the stock remains liquid enough for trading, and its ability to service debt is supported by a low Debt to EBITDA ratio of 1.28 times. Additionally, the company has demonstrated healthy long-term growth with an annual operating profit increase of 60.53%.
In the broader market context, Shukra Pharmaceuticals has outperformed the benchmark, with a 1-week return of 13.84% compared to the Sensex's 2.00%. This trend of strong performance is evident across various time frames, including a staggering 2349.77% return over the past three years. The stock's consistent gains and market-beating performance indicate positive investor sentiment, contributing to its rising price. Overall, the combination of strong financial health, impressive growth metrics, and favorable market conditions has led to the stock's upward movement.